Intuitive Surgical's da Vinci 5 System Gains FDA Approval for Cardiac Procedures

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve repair and cardiac revascularization. The approval enables minimally invasive approaches in traditionally open procedures, expanding the company's established robotics franchise. Shares are mixed, with a 94.5% return over 3 years and 101.1% over 5 years, but a 12.5% decline over the past year. The key question is how quickly hospitals and cardiac teams adopt minimally invasive robotic approaches.